Information Provided By:
Fly News Breaks for March 13, 2017
HOLX
Mar 13, 2017 | 07:39 EDT
Jefferies analyst Raj Denhoy raised his price target for Hologic to $49 from $46 saying adoption of 3D mammography "appears to be on the cusp of an inflection." In the conversion from analog to 2D digital, growth accelerated dramatically in year seven, which is where we are in the 3D cycle, Denhoy tells investors in a research note. He adds that his firm's survey of 25 hospitals suggests that 3D penetration will continue with Hologic the main beneficiary. Denhoy keeps a Buy rating on the shares.
News For HOLX From the Last 2 Days
There are no results for your query HOLX